"Methodist Le Bonheur Healthcare in Memphis, TN, in partnership with its medical staffs, will collaborate with patients and their families to be the leader in providing high quality, cost-effective patient-and family-centered care. Services will be provided in a manner which supports the health ministries and Social Principles of The United Methodist Church to benefit the communities we serve."

During the past decade, Methodist University Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 19 clinical trials were completed, i.e. on average, 57.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 12 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Methodist University Hospital" #1 sponsor was "Abbott Medical Devices" with 10 trials, followed by "Methodist Healthcare" with 5 trials sponsored, "Microvention-Terumo, Inc." with 4 trials sponsored, "University of Tennessee" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 44 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Methodist University Hospital" #1 collaborator was "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator, "Medical University of South Carolina" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "University of Cincinnati" with 3 trials as a collaborator and "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Methodist University Hospital" are "Heart Failure" (8 trials), "Stroke" (6 trials), "HIV Infections" (5 trials), "Intracranial Aneurysms" (3 trials) and "Ischemic Stroke" (3 trials). Many other conditions were trialed in "Methodist University Hospital" in a lesser frequency.

Most popular intervention types in "Methodist University Hospital" are "Drug" (38 trials), "Device" (26 trials), "Procedure" (9 trials), "Other" (8 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Amprenavir" (2 trials), "Apixaban" (2 trials), "Aspirin" (2 trials) and "Empagliflozin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Methodist University Hospital" are 71 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Methodist University Hospital". undefined are not yet recruiting, 7 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Methodist University Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Methodist University Hospital, 5 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 23 trials that are defined as “Not Applicable".

Methodist University Hospital has several departments that took part in Clinical trials: "University of Tennessee Cancer Institute at Methodist Central Hospital" - 8 trials, "Sutherland Cardiology Clinic" - 5 trials, "University of Tennessee Methodist Physicians" - 2 trials